(Q78726480)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505182%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

title

Mucosal leishmaniasis: in situ characterization of the host inflammatory response, before and after treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505182%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author

Maria Irma Seixas Duarte

series ordinal

3

object named as

Maria Irma Seixas Duarte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505182%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

Valdir Sabbaga Amato

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505182%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Heitor Franco de Andrade

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505182%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505182%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505182%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505182%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505182%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

39-49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505182%20AND%20SRC:MED&resulttype=core&format=json

An evaluation of clinical, serologic, anatomopathologic and immunohistochemical findings for fifteen patients with mucosal leishmaniasis before and after treatment

16 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Use of itraconazole in the treatment of mucocutaneous leishmaniasis: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Evaluation of T-cell subsets in the lesion infiltrates of human cutaneous and mucocutaneous leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Human_leishmaniasis/cytokines.bahia.br

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

The biology of cachectin/TNF--a primary mediator of the host response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Histopathology of human American cutaneous leishmaniasis before and after treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysacchari

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Tumor necrosis factor-alpha in human american tegumentary leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Cell populations in the lesion of human cutaneous leishmaniasis: a light microscopical, immunohistochemical and ultrastructural study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Clinical healing of antimony-resistant cutaneous or mucocutaneous leishmaniasis following the combined administration of interferon-gamma and pentavalent antimonial compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Strategies of obligate intracellular parasites for evading host defences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Mucosal leishmaniasis ("espundia" Escomel, 1911).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Regulation of interferon-gamma production by IL-12 and IL-18.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

[An evolutionary study of mucosal leishmaniasis (a 7- to 17-year follow-up) due to Leishmania (Viannia) braziliensis in Tres Braços, Bahia]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Cytokine patterns in the pathogenesis of human leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Imported mucocutaneous leishmaniasis in New York City. Report of a patient treated with amphotericin B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

Expansion of gamma interferon-producing CD8+ T cells following secondary infection of mice immune to Leishmania major

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900260-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0001-706X(02)00260-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505182%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference